Skip to navigation Skip to main content
preloader
  • Home
  • About Us
  • Technologies & Applications
    • Regenerative Medicine Applications | Amniotic Fluid Stem Cells
    • Regenerative Medicine Applications | Exosomes
    • Aesthetic Medicine Applications | Deer-Derived Exosomes
    • Healthcare & Wellness Series | Deer Velvet Antler Peptide ACT.A
  • New Drug Development
  • i-ExoCraft®
  • News & Updates
    • Video Gallery
    • Press Coverage
      • Drug Development & Regulatory Affairs
      • Technology Platform & R&D
      • International Expansion & Out-Licensing
      • Products & Commercial Partnerships
  • Investor Relations
  • Contact Us
  • English
    • Chinese (Traditional)

Investor Zone

Expanding into ASEAN: U-NEURON Partners with Malaysia’s SBC

Collaborating on Amniotic Fluid Stem Cell Clinical Applications and Research; Full Line of Nutritional Products Scheduled for Market Launch in 2025
Continue reading

U-NEURON’s ED Drug UA002 Validates Phase 1 Safety Profile

U-NEURON (6973), a biotech companylistedon Taiwan’s Emerging Stock Market, announced on the 3rd that Phase 1 clinical trial enrollment for its novel therapeutic UA002, targeting male erectile dysfunction (ED), has been completed, with Phase 2 trials set to commence.
Continue reading
  • 1
  • 2
  • 3
  • 4

Tel: 02-2697-5599 | Email: service@u-neuron.com | Address: 18F.-5, No. 99, Sec. 1, Xintai 5th Rd., Xizhi Dist., New Taipei City, Taiwan

Copyright © 2026 All Rights Reserved.

Tel: 02-2697-5599
Email: service@u-neuron.com
Address: 18F.-5, No. 99, Sec. 1, Xintai 5th Rd., Xizhi Dist., New Taipei City, Taiwan

Copyright © 2026 All Rights Reserved.

  • Home
  • About Us
  • Technologies & Applications
    • Regenerative Medicine Applications | Amniotic Fluid Stem Cells
    • Regenerative Medicine Applications | Exosomes
    • Aesthetic Medicine Applications | Deer-Derived Exosomes
    • Healthcare & Wellness Series | Deer Velvet Antler Peptide ACT.A
  • New Drug Development
  • i-ExoCraft®
  • News & Updates
    • Video Gallery
    • Press Coverage
      • Drug Development & Regulatory Affairs
      • Technology Platform & R&D
      • International Expansion & Out-Licensing
      • Products & Commercial Partnerships
  • Investor Relations
  • Contact Us
  • English
    • Chinese (Traditional)
  • 聯繫顧問
  • 索取資料
  • 預約會議
English Chinese (Traditional)
EnglishChinese (Traditional)